ABOUT I-MAK The Initiative for Medicines, Access and Knowledge (I-MAK) is a 501(c)(3) organization with a mission to build a more just and equitable medicines system
SGLT2 inhibitors Drugs like empagliflozin (Jardiance) and dapagliflozin (Farxiga) are sodium-glucose cotransporter 2 inhibitors
The most common questions we get are: are they safe together, do they interfere with each other, and is combining them actually worth it
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N -methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder
MusthafaQAAbdul ShukorMFIsmailNASMohd GhaziAMohd AliRNorIFet alOxidative status and reduced glutathione levels in premature coronary artery disease and coronary artery disease
Injection details: Date, time, dose, units drawn, injection site, any issues